Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;10(8):851-855.
doi: 10.1001/jamacardio.2025.1399.

Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use

Affiliations

Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use

Leila Mohammadi et al. JAMA Cardiol. .

Erratum in

  • Error in Abstract and Methods.
    [No authors listed] [No authors listed] JAMA Cardiol. 2025 Aug 1;10(8):864. doi: 10.1001/jamacardio.2025.2405. JAMA Cardiol. 2025. PMID: 40632509 Free PMC article. No abstract available.

Abstract

Importance: Recreational and medicinal cannabis legalization has led to increased cannabis use. To understand the consequences for vascular health, we initiated the CANnabis: Does It Damage Endothelium (CANDIDE) study.

Objective: To investigate whether cannabis use is associated with vascular endothelial dysfunction.

Design, setting, and participants: In this cross-sectional study, age-matched healthy adults, aged 18 to 50 years, living in the San Francisco Bay Area, California, who neither smoke tobacco nor vape and were not frequently exposed to secondhand smoke were recruited into 3 cohorts: 2 chronic cannabis user groups (marijuana smokers and tetrahydrocannabinol [THC]-edible users) and 1 nonuser group. Participants were recruited from October 25, 2021, through August 1, 2024; analysis was completed September 2024. Participants' arterial flow-mediated dilation (FMD) and carotid-femoral pulse wave velocity (PWV) were measured. Human umbilical vein endothelial cells (HUVECs) were exposed to participant sera with and without vascular endothelial growth factor (VEGF) to assess the effects of user serum on endothelial nitric oxide production.

Main outcomes and measures: FMD and PWV were direct physiological measurements, and VEGF-stimulated nitric oxide production was measured from HUVECs incubated in user serum samples.

Results: Among 55 participants (20 female [37%]; 35 male [63%], mean age, 31.3 [SD, 8.4] years) arterial FMD was significantly lower among the marijuana smokers (mean, 6.0% [SD, 2.6%]; P = .004) and lower among THC-edible users (mean, 4.6% [SD, 3.7%]; P = .003) than among nonusers (mean, 10.4% [SD, 5.2%]). VEGF-stimulated nitric oxide levels in endothelial cells treated with participants' sera were significantly lower for the marijuana smoker group (mean, 1.1 nmol/L [SD, 0.3 nmol/L] ) than for the nonuser group (mean, 1.5 nmol/L [SD, 0.3 nmol/L]; P = .004) but were unaffected among the THC-edible users group compared with the nonusers (mean, 1.5 nmol/L [SD, 0.3 nmol/L]; P = .81). FMD was inversely correlated with smoking frequency (r = -0.7; P < .001) and the amount of THC ingested (r = -0.7; P = .03). Other vascular properties showed no differences.

Conclusions: This cross-sectional study found that chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction similar to that observed in tobacco smokers, although apparently occurring via distinct mechanisms.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cheng reported receiving grants from the NIH during the conduct of the study. Dr Wu reported being a cofounder and member of the science advisory board of Greenstone Biosciences outside the submitted work. Dr Springer reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) with the US Food and Drug Administration (FDA) Center for Tobacco Products, the California Tobacco-Related Disease Research Program, the UC Berkeley Bakar Fellows Program, Larix Bioscience from a Small Business Innovation Research subcontract, and intramural support from the University of California, San Francisco (UCSF) outside the submitted work. Dr Mohammadi reported receiving a grant from the California Tobacco-Related Disease Research Program outside the submitted work. No other disclosures were reported.

References

    1. Pope CA III, Burnett RT, Krewski D, et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120(11):941-948. doi: 10.1161/CIRCULATIONAHA.109.857888 - DOI - PubMed
    1. Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21(2):494-502. doi: 10.1021/tx700275p - DOI - PubMed
    1. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. J Am Heart Assoc. 2024;13(5):e030178. doi: 10.1161/JAHA.123.030178 - DOI - PMC - PubMed
    1. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111-1115. doi: 10.1016/0140-6736(92)93147-F - DOI - PubMed
    1. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120(6):502-509. doi: 10.1161/CIRCULATIONAHA.109.864801 - DOI - PMC - PubMed